Comparison of Haloperidol and Opium Tincture in the control of clinical signs associated with methamphetamine

Vice Chancellor for Research, University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Dependence on methamphetamine (more than 10 times the regular use of methamphetamine or 10 days); Urine tests positive for methamphetamine; Age 18-65 years; Independence and no use of drugs or other addictive drugs at the time of presentation; Complete the consent form; To track patient;
•Exclusion criteria: Unwillingness person to continue treatment; Patient self-medication or participate in another study; Other addictive drugs or alcohol or drug use during the study period; Non-compliance with medication orders during the study; Coming out of treatment (imprisonment, death, ...); Any behavior that resulted in dismissal laws rehab clinic patient; There are other mental disorders that require treatment or the risk of suicide; Significant diseases of the Thyroid, Kidney, Liver, Gastrointestinal or Cardiovascular; History of diabetes or Heart attack, Seizures, Glaucoma, Tick, Tardive dyskinesia; Female without adequate contraception pregnancy or lactation; Tincture of opium abusers; A history of allergy to Haloperidol; Simultaneous treatment with antipsychotics or mood stabilizers or CYP 2D6 inhibitors Contains: Amiodarone, Bupropion, Celecoxib, Cimetidine, Chlorpromazine, Clomipramine, Fluoxetine, Haloperidol, Methadone, Moclobemide, Paroxetine, Quinidine, Ritonavir, Sertraline, Terbinafine and Thioridazine; So dangerous side effects of medications or the patient is intolerable.

发起方

Vice Chancellor for Research, University of Medical Sciences